With Ad FoxO6 transfection and Ang‐II treatment, FoxO6 overexpression further exacerbated cardiac hypertrophy and increased the expression of β‐MHC, ANP, and TGF‐β1 (Figure S6E–H). This evidence concerns the gene AGT and cardiac hypertrophy.